Literature DB >> 11944085

Claudin 5 is transiently expressed during the development of the retinal pigment epithelium.

S Kojima1, C Rahner, S Peng, L J Rizzolo.   

Abstract

During the development of chick retinal pigment epithelium (RPE), the permeability and selectivity of the epithelium's tight junctions are continuously modulated. Overall paracellular permeability decreases, but selectivity increases. Because the claudin family of transmembrane proteins appears to provide the structural basis for selectivity, we examined the expression of claudins as a function of development in chick RPE. Degenerate primers were used with the reverse transcriptase-polymerase chain reaction (RT-PCR) to obtain complete sequences of chick claudins 3 and 5. Northern blotting and semi-quantitative RT-PCR demonstrated that claudin 5 was expressed in RPE, but claudin 3 was expressed only in the choroid layer of the eye. Northern blotting, semiquantitative RT-PCR and immunoblotting demonstrated that the expression of claudin 5 was transient, with peak levels of expression between embryonic days 10 and 14. Primary cultures were used to demonstrate that factors secreted by the neural retina induced the expression of claudin 5 nearly 3-fold if RPE was isolated from embryonic day 7 embryos. There was little effect if RPE was isolated from embryonic day 14. The upregulation of claudin 5 correlates with permeability changes that occur during the intermediate stage of RPE development. Interestingly, claudin 5 must be replaced during the late stage of development when the number and complexity of tight junctional strands increases. This would imply more changes in selectivity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11944085     DOI: 10.1007/s00232-001-0137-7

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  12 in total

1.  The tight junction protein claudin-1 influences cranial neural crest cell emigration.

Authors:  Katherine J Fishwick; Theresa E Neiderer; Sharon Jhingory; Marianne E Bronner; Lisa A Taneyhill
Journal:  Mech Dev       Date:  2012-07-03       Impact factor: 1.882

2.  An experimental platform for systemic drug delivery to the retina.

Authors:  Matthew Campbell; Anh T H Nguyen; Anna-Sophia Kiang; Lawrence C S Tam; Oliviero L Gobbo; Christian Kerskens; Sorcha Ni Dhubhghaill; Marian M Humphries; G-Jane Farrar; Paul F Kenna; Peter Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

3.  Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue.

Authors:  Arvydas Maminishkis; Shan Chen; Stephen Jalickee; Tina Banzon; Guangpu Shi; Fei E Wang; Todd Ehalt; Jeffrey A Hammer; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

4.  Laurate permeabilizes the paracellular pathway for small molecules in the intestinal epithelial cell model HT-29/B6 via opening the tight junctions by reversible relocation of claudin-5. [Corrected].

Authors:  Isabel Dittmann; Maren Amasheh; Susanne M Krug; Alexander G Markov; Michael Fromm; Salah Amasheh
Journal:  Pharm Res       Date:  2014-03-15       Impact factor: 4.200

5.  RPE barrier breakdown in diabetic retinopathy: seeing is believing.

Authors:  Hui-Zhuo Xu; Zhiming Song; Shuhua Fu; Meili Zhu; Yun-Zheng Le
Journal:  J Ocul Biol Dis Infor       Date:  2011-12-31

6.  Claudins and tricellulin in fibrolamellar hepatocellular carcinoma.

Authors:  Attila Patonai; Boglárka Erdélyi-Belle; Anna Korompay; Aron Somorácz; Beate K Straub; Peter Schirmacher; Ilona Kovalszky; Gábor Lotz; András Kiss; Zsuzsa Schaff
Journal:  Virchows Arch       Date:  2011-04-19       Impact factor: 4.064

7.  Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain.

Authors:  Tracy A Brooks; Scott M Ocheltree; Melissa J Seelbach; Rachael A Charles; Nicole Nametz; Richard D Egleton; Thomas P Davis
Journal:  Brain Res       Date:  2006-09-27       Impact factor: 3.252

8.  Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain.

Authors:  Patrick T Ronaldson; Kristin M Demarco; Lucy Sanchez-Covarrubias; Christine M Solinsky; Thomas P Davis
Journal:  J Cereb Blood Flow Metab       Date:  2009-03-25       Impact factor: 6.200

9.  Selective decrease in paracellular conductance of tight junctions: role of the first extracellular domain of claudin-5.

Authors:  Huajie Wen; Debbie D Watry; M Cecilia G Marcondes; Howard S Fox
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

10.  Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier.

Authors:  Christopher R Campos; Scott M Ocheltree; Sharon Hom; Richard D Egleton; Thomas P Davis
Journal:  Brain Res       Date:  2008-05-17       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.